Literature DB >> 30325283

Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes.

Gu-Wei Ji1, Yu-Dong Zhang1, Hui Zhang1, Fei-Peng Zhu1, Ke Wang1, Yong-Xiang Xia1, Yao-Dong Zhang1, Wang-Jie Jiang1, Xiang-Cheng Li1, Xue-Hao Wang1.   

Abstract

Purpose To evaluate a radiomics model for predicting lymph node (LN) metastasis in biliary tract cancers (BTCs) and to determine its prognostic value for disease-specific and recurrence-free survival. Materials and Methods For this retrospective study, a radiomics model was developed on the basis of a primary cohort of 177 patients with BTC who underwent resection and LN dissection between June 2010 and December 2016. Radiomic features were extracted from portal venous CT scans. A radiomics signature was built on the basis of reproducible features by using the least absolute shrinkage and selection operator method. Multivariable logistic regression model was adopted to establish a radiomics nomogram. Nomogram performance was determined by its discrimination, calibration, and clinical usefulness. The model was internally validated in 70 consecutive patients with BTC between January 2017 and February 2018. Results The radiomics signature, composed of three LN-status-related features, was associated with LN metastasis in primary and validation cohorts (P < .001). The radiomics nomogram that incorporated radiomics signature and CT-reported LN status showed good calibration and discrimination in primary cohort (area under the curve, 0.81) and validation cohort (area under the curve, 0.80). Patients at high risk of LN metastasis portended lower disease-specific and recurrence-free survival than did those at low risk after surgery (both P < .001). High-risk LN metastasis was an independent preoperative predictor of disease-specific survival (hazard ratio, 3.37; P < .001) and recurrence-free survival (hazard ratio, 1.98; P = .003). Conclusion A radiomics model derived from portal phase CT of the liver has good performance for predicting lymph node metastasis in biliary tract cancer and may help to improve clinical decision making. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Laghi and Voena in this issue.

Entities:  

Mesh:

Year:  2018        PMID: 30325283     DOI: 10.1148/radiol.2018181408

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  58 in total

1.  Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement.

Authors:  Ji Eun Park; Donghyun Kim; Ho Sung Kim; Seo Young Park; Jung Youn Kim; Se Jin Cho; Jae Ho Shin; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

2.  Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.

Authors:  Ruichuan Shi; Weixing Chen; Bowen Yang; Jinglei Qu; Yu Cheng; Zhitu Zhu; Yu Gao; Qian Wang; Yunpeng Liu; Zhi Li; Xiujuan Qu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.

Authors:  Ryota Nakanishi; Takashi Akiyoshi; Shigeo Toda; Yu Murakami; Senzo Taguchi; Koji Oba; Yutaka Hanaoka; Toshiya Nagasaki; Tomohiro Yamaguchi; Tsuyoshi Konishi; Shuichiro Matoba; Masashi Ueno; Yosuke Fukunaga; Hiroya Kuroyanagi
Journal:  Ann Surg Oncol       Date:  2020-08-07       Impact factor: 5.344

4.  A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.

Authors:  Gu-Wei Ji; Fei-Peng Zhu; Yu-Dong Zhang; Xi-Sheng Liu; Fei-Yun Wu; Ke Wang; Yong-Xiang Xia; Yao-Dong Zhang; Wang-Jie Jiang; Xiang-Cheng Li; Xue-Hao Wang
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

5.  MRI-based radiomics analysis to predict preoperative lymph node metastasis in papillary thyroid carcinoma.

Authors:  Wenjuan Hu; Hao Wang; Ran Wei; Lanyun Wang; Zedong Dai; Shaofeng Duan; Yaqiong Ge; Pu-Yeh Wu; Bin Song
Journal:  Gland Surg       Date:  2020-10

6.  Nodal-based radiomics analysis for identifying cervical lymph node metastasis at levels I and II in patients with oral squamous cell carcinoma using contrast-enhanced computed tomography.

Authors:  Hayato Tomita; Tsuneo Yamashiro; Joichi Heianna; Toshiyuki Nakasone; Yusuke Kimura; Hidefumi Mimura; Sadayuki Murayama
Journal:  Eur Radiol       Date:  2021-03-31       Impact factor: 5.315

7.  Noncontrast computer tomography-based radiomics model for predicting intracerebral hemorrhage expansion: preliminary findings and comparison with conventional radiological model.

Authors:  Huihui Xie; Shuai Ma; Xiaoying Wang; Xiaodong Zhang
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315

8.  Magnetic resonance imaging (MRI) radiomics of papillary thyroid cancer (PTC): a comparison of predictive performance of multiple classifiers modeling to identify cervical lymph node metastases before surgery.

Authors:  Hui Qin; Qiao Que; Peng Lin; Xin Li; Xin-Rong Wang; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Radiol Med       Date:  2021-07-08       Impact factor: 3.469

9.  Feasibility of an ADC-based radiomics model for predicting pelvic lymph node metastases in patients with stage IB-IIA cervical squamous cell carcinoma.

Authors:  Yan Yan Yu; Rui Zhang; Rui Tong Dong; Qi Yun Hu; Tao Yu; Fan Liu; Ya Hong Luo; Yue Dong
Journal:  Br J Radiol       Date:  2019-04-01       Impact factor: 3.039

10.  Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning.

Authors:  Jun Zhang; Zixing Huang; Likun Cao; Zhen Zhang; Yi Wei; Xin Zhang; Bin Song
Journal:  Ann Transl Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.